LAB

Standard BioTools (LAB) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.

Deals

Standard BioTools Holders Would Own About 16% Of Treeline Combination, Amended S-4 Shows

The second amended filing sets an exchange ratio range, a 12-seat board and a $2.5 billion Treeline value against $460 million for Standard BioTools.

Deals

Standard BioTools Agrees To Sell Microfluidics Business To ARCHIMED, With Closing Targeted In About 30 Days

The 8-K does not state a price for the Microfluidics sale, the second unit Standard BioTools has moved to sell.